InsidersTradesSigma
申报总数
公司
▲ 买入（6 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
6
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-10.8%
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Legorreta Pablo G., 董事. Insider active across 3 companies, notably Royalty Pharma plc. In total, 20 disclosures have been recorded. Split: 6 buys · 0 sell. Total volume traded: €95.8m. History available since 7 May 2021. The latest transaction was disclosed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Legorreta Pablo G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
65,216 股0Class A Ordinary SharesSEC:0001507678-26-000006:0
157,828 股0Class A Ordinary SharesSEC:0001507678-26-000002:0
36,559 股0Class A Ordinary SharesSEC:0001507678-25-000010:0
21,901 股0Class A Ordinary SharesSEC:0001802768-25-000105:0
3,823,996 股0Class A Ordinary SharesSEC:0000950170-25-082342:0
530,348 股0Class A Ordinary SharesSEC:0001802768-25-000063:0
288,352 股0Class A Ordinary SharesSEC:0001802768-25-000039:0
532,535 股0Class A Ordinary SharesSEC:0000950170-25-015495:0
22,617,909 股@ US$2.42100.0% 占其流量Class A Ordinary SharesSEC:0000950170-24-073633:0
标准退出：2024年9月11日 (T+90)
748,952 股0Class A Ordinary SharesSEC:0000950170-24-011711:0
292,190.49 股0Class A ordinary sharesSEC:0000950103-23-016404:0
5,289,055 股0Class A Ordinary SharesSEC:0001209191-23-054044:0
130,000 股@ US$29.513624.5% 占其流量Class A ordinary sharesSEC:0001209191-23-040024:0
标准退出：2023年9月26日 (T+90)
45,000 股@ US$32.99889.6% 占其流量Class A ordinary sharesSEC:0001209191-23-036624:0
标准退出：2023年9月10日 (T+90)
150,000 股@ US$32.249631.3% 占其流量Class A ordinary sharesSEC:0000950103-23-007785:0
标准退出：2023年8月22日 (T+90)
160,388 股@ US$33.566934.5% 占其流量Class A ordinary sharesSEC:0000950103-23-007427:0
标准退出：2023年8月14日 (T+90)
31,933,334 股Common Stock, par value $0.0001SEC:0000899243-22-028860:0
493,750 股0Class A Ordinary SharesSEC:0000950103-22-006475:0
22,666,667 股@ US$1.50100.0% 占其流量Common StockSEC:0000899243-22-003857:0
标准退出：2022年5月1日 (T+90)
1,040,410 股0Class A Ordinary SharesSEC:0000950103-21-007075:0
20 条申报中的 20 条
About Legorreta Pablo G.
Legorreta Pablo G. is Chief Executive Officer, Chairman and Director. He has filed 19 filings in total, and across the 19 sampled recent filings the recorded transactions are purchases for EUR 95802560 and no sales, between 2021-05-11 and 2026-02-13. The largest recent filings concern Prokidney CORP., Epizyme, Inc. and Royalty Pharma plc.
